Helena Wallin

Artiklar

Article: BMC NEPHROLOGY. 2020;21(1):475

Aerobic exercise capacity is maintained over a 5-year period in mild-to-moderate chronic kidney disease: a longitudinal study.

Wallin H; Jansson E; Wallquist C; Hylander Rössner B; Jacobson SH; Rickenlund A; Eriksson MJ
Article: PLOS ONE. 2018;13(12):e0209325

Gradual reduction in exercise capacity in chronic kidney disease is associated with systemic oxygen delivery factors.

Wallin H; Asp AM; Wallquist C; Jansson E; Caidahl K; Hylander Rössner B; Jacobson SH; Rickenlund A; Eriksson MJ
Article: ANNALS OF THE RHEUMATIC DISEASES. 2012;71(2):186-191

In early rheumatoid arthritis, patients with a good initial response to methotrexate have excellent 2-year clinical outcomes, but radiological progression is not fully prevented: data from the methotrexate responders population in the SWEFOT trial.

Rezaei H; Saevarsdottir S; Forslind K; Albertsson K; Wallin H; Bratt J; Ernestam S; Geborek P; Pettersson IF; van Vollenhoven RF
Article: ANNALS OF THE RHEUMATIC DISEASES. 2011;70(3):469-475

Predictors of response to methotrexate in early DMARD naive rheumatoid arthritis: results from the initial open-label phase of the SWEFOT trial.

Saevarsdottir S; Wallin H; Seddighzadeh M; Ernestam S; Geborek P; Petersson IF; Bratt J; van Vollenhoven RF; SWEFOT Trial Investigators Group

Medicine Doktorsexamen, Institutionen för laboratoriemedicin, Karolinska Institutet, 2023